Pharminent

NICE backs Celgene’s Otezla for psoriatic arthritis

Celgene’s Otezla is being backed for routine use on the National Health Service in England and Wales to treat psoriatic arthritis. http://www.pharmatimes.com/news/nice_backs_celgenes_otezla_for_psoriatic_arthritis_1160072

Filed under: Arthritis